CORD BLOOD AMERICA, INC. (OTCMKTS:CBAI) Files An 8-K Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition.
the Press Release attached as Exhibit 99.1 to this Current
Report. The Press Release provides details related to the
Companys financial results and earnings for the three month
period ended March 31, 2017.The information included in Exhibit
99.1 is considered to be furnished under the Securities Exchange
Act of 1934.
|
Exhibit No.
|
Description
|
|
|
99.1
|
Press Release dated May 15, 2017
|
About CORD BLOOD AMERICA, INC. (OTCMKTS:CBAI)
Cord Blood America, Inc. (CBAI), through its CorCell program and its subsidiary CorCell Companies, Inc., provides cord blood and cord tissue stem cell services. CBAI’s subsidiaries include Cord Partners, Inc., CorCell Companies, Inc., CorCell, Ltd., (Cord Partners, Inc., CorCell Companies, Inc. and CorCell, Ltd. are referred to collectively as Cord), CBA Properties, Inc. (Properties), and Career Channel, Inc. CBAI and its subsidiaries engage in the various business activities, such as CBAI and Cord specialize in providing private cord blood and cord tissue stem cell storage services to families throughout the United States and Puerto Rico, and Properties was formed to hold corporate trademarks and other intellectual property. Cord’s operations provide umbilical cord blood banking and cord tissue services to expectant parents. Cord provides various services, which includes collection materials, physician and customer support, transportation, testing and cord blood storage. CORD BLOOD AMERICA, INC. (OTCMKTS:CBAI) Recent Trading Information
CORD BLOOD AMERICA, INC. (OTCMKTS:CBAI) closed its last trading session down -0.00030 at 0.00260 with shares trading hands.
